Title:
Exploiting Collateral Sensitivity to Win the War Against Antimicrobial Resistance
Agreement Value:
$12,500.00
Agreement Date:
Mar 25, 2020 - Mar 31, 2021
Description:
Many antibiotics are derived from natural products, small molecules made by organisms in the environment. In this project, high-throughput screening and chemical analysis will be used to isolate and identify novel natural products with unique activities against drug-resistant strains of E. coli. Using this approach, it is anticipated that a new classes of bioactive compounds will be identified that could form the foundation for future drug development.
Organization:
National Research Council Canada
Expected Results:
In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators.
Location:
BURNABY, British Columbia, CA V5A 1S6
Reference Number:
172-2019-2020-Q4-946583
Report Type:
Grants and Contributions
Recipient Business Number:
118520725
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 182 days. The total amended value is 29,900 dollars.
Recipient's Operating Name:
Simon Fraser University
Recipient's Legal Name:
Simon Fraser University
Federal Riding Name:
Burnaby North–Seymour
Federal Riding Number:
59002
Program:
Collaborative Science, Technology and Innovation Program – Ideation Fund
Program Purpose:
The Ideation Fund is intended to encourage, test and validate transformative research ideas generated by teams of NRC scientific personnel and external collaborators with complementary capabilities, acting as a demonstration phase for a continually-evolving suite of research and development (R&D) deliverables at the NRC. The fund supports exploratory research through two mechanisms: the New Beginnings Initiative and the Small Teams Initiative.